SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as investors digest the announcement of Josh D'Amaro as the new CEO, sparking intense debate over whether the leadership transition will resolve long-standing concerns regarding content strategy and stagnant stock performance. While some community members see the change as a catalyst for a long-term turnaround supported by strong theme park revenue, others remain skeptical, citing ongoing debt management and the company's struggle to reclaim its historical market momentum.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as investors weigh strong profitability and strategic share buybacks against recent multi-billion dollar writedowns tied to a pivot away from aggressive EV capacity. The community is actively debating the company's ability to maintain its competitive edge and margin growth amidst shifting automotive regulations and the ongoing transition between gas-powered trucks and electrification.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is attracting attention due to a combination of persistent insider buying from the CEO and a potential turnaround narrative following a recent leadership transition. While some investors view the stock's discounted valuation and insider activity as a strong signal for a rebound, others remain skeptical, citing ongoing profitability challenges and intense competition from AI-integrated enterprise software.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining momentum as investors react to a series of strategic milestones, including expanded partnerships with U.S. Department of Energy national labs and a high-profile presence at the NVIDIA GTC conference. Community sentiment is deeply divided between long-term believers who are aggressively accumulating shares due to the company's defense-focused quantum hardware, and skeptics who are wary of recent downward price action following the company's de-SPAC process.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is seeing significant market activity as investors weigh recent regulatory milestones, including a new materials license for its subsidiary Atomic Alchemy and Department of Energy approval, against the backdrop of its pre-revenue status and high cash burn. The community remains deeply divided, with some betting on a long-term role in AI data center power, while others express skepticism over the company's ambitious construction timelines and insider share sales.

D.R. Horton, Inc. engages in the construction and sale of single-family housing. It operates through the following geographical segments: Northwest, Southwest, South Central, Southeast, East, and North. The Northwest segment relates to Colorado, Oregon, Utah, and Washington. The Southwest segment covers Arizona, California, Hawaii, Nevada, and New Mexico. The South Central segment is involved in Arkansas, Oklahoma, and Texas. The Southeast segment refers to Alabama, Florida, Louisiana, and Mississippi. The East segment operates Georgia, North Carolina, South Carolina, and Tennessee. The North segment focuses on Delaware, Illinois, Indiana, Iowa, Kentucky, Maryland, Minnesota, Nebraska, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia. The company was founded by Donald Ray Horton in 1978 and is headquartered in Arlington, TX.

D.R. Horton Inc.

D.R. Horton is facing increased selling pressure as the housing sector grapples with ongoing affordability challenges, rising inventory levels, and concerns that persistent mortgage rates may limit demand despite recent sector-wide volatility. Investors are actively debating the sustainability of current homebuilder valuations, closely monitoring upcoming earnings and economic indicators to gauge if the sector is nearing a bottom or bracing for further correction.

Ferrari NV is a holding company, which engages in the design, engineering, production, and sale of luxury sports cars. The firm's models include the F12Berlinetta, 488GTB, 488 Spider, 458 Speciale, California T, the LaFerrari Hybrid, LaFerrari, and the FF four-wheel drive. It participates in car racing such as Formula One. The company was founded by Enzo Anselmo Ferrari in 1939 and is headquartered in Maranello, Italy.

Ferrari N.V.

Ferrari shares are experiencing significant volatility following a strategic update that reduced the company's 2030 electric vehicle targets, leading investors to weigh the impact on long-term margins and electrification costs. Despite the price dip, the community remains actively divided between those concerned about the shift in growth outlook and long-term believers who see the stock as an exclusive, high-margin asset that continues to benefit from strong brand pricing power.

Global X Funds - Global X Uranium ETF

Global X Uranium ETF

The uranium sector is currently oscillating between strong long-term fundamental demanddriven by AI data center energy needs and government push for nuclear independenceand short-term volatility stemming from corrective technical structures. While community sentiment remains largely bullish, investors are actively debating whether to buy current pullbacks or await further consolidation as the ETF navigates a complex macro environment.

SM Energy Co. is an independent energy company, which engages in the provision of acquisition, exploration, development, and production of oil, gas, and natural gas liquids. The company was founded in 1908 and is headquartered in Denver, CO.

SM Energy Co

SM Energy is seeing renewed investor interest driven by recent analyst upgrades, including an overweight rating from JPMorgan, which highlights potential for increased shareholder returns and an attractive valuation gap compared to its peers. The community is actively discussing the stock's resilience, the impact of rising oil prices on its cash flow, and potential upside scenarios, though some participants remain cautious due to broader sector volatility.

Global X Funds - Global X Copper Miners ETF

The community is closely watching the Global X Copper Miners ETF ($COPX) as investors debate whether recent volatility represents a healthy accumulation period before a structural bull market or a deeper correction linked to broader economic jitters. While some traders are expressing frustration over recent price weakness, many remain focused on a long-term bullish thesis driven by supply-side deficits and the critical role copper plays in AI infrastructure, defense, and grid modernization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Acurx Pharmaceuticals (ACXP) points to a 226.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.

AI, Diagnostics and Next-Gen Materials Drive Innovation Push Across Emerging Growth Stocks

A wave of developments across emerging technology and life sciences companies underscores how artificial intelligence, advanced diagnostics, and next-generation biomaterials are converging to reshape several high-growth sectors. $ISPC, $AIFF, $KBLB, $BIAF, $ACXP, $KIDZ

Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business...

Best Pharmaceutical Stocks To Follow Now - March 11th

Eli Lilly and Company, Pfizer, Vertex Pharmaceuticals, AbbVie, Abbott Laboratories, Acurx Pharmaceuticals, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to...

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today?

Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session.read more...

Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection

Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection Acurx...

Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update

Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update Acurx Pharmaceuticals to Discuss Full Year and...

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals

Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals Health~Holland Awards Another Innovative Research...

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.

ACXP
Acurx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results:

Historical Earnings

Latest ACXP News

ACXPAcurx Pharmaceuticals Inc